Varian Medical Systems Newswire (Page 6)

Varian Medical Systems Newswire (Page 6)

Comprehensive Real-Time News Feed for Varian Medical Systems. (Page 6)

Results 101 - 120 of 3,189 in Varian Medical Systems

  1. Varian Medical Systems, Inc. (VAR) Shares Bought by Amalgamated BankRead the original story w/Photo

    Sep 26, 2017 | IntersportsWire

    Amalgamated Bank lifted its stake in Varian Medical Systems, Inc. by 50.5% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,812 shares of the medical equipment provider's stock after purchasing an additional 3,630 shares during the quarter.

    Comment?

  2. Global Particle Beam Radiation Therapy System Market 2017:...Read the original story w/Photo

    Sep 25, 2017 | SBWire

    ... Analysis of Particle Beam Radiation Therapy System Market: By Vendors 1. Mitsubishi Electric 2. Varian Medical Systems 3. Mevion Medical Systems 4. Advanced Oncotherapy Analysis of Global Particle Beam Radiation Therapy System Market: By Regions - ...

    Comment?

  3. Fusion Pharmaceuticals Completes Oversubscribed Series A Financing...Read the original story

    Sep 24, 2017 | Venture Capital Access Online

    Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced it has completed a second closing of its Series A financing, securing an additional $21 million USD in capital and bringing the total capital raised to $46 million USD. New investors in the second closing include Adams Street Partners, Seroba Life Sciences, and Varian Medical Systems Inc., who join the existing group of international investors, FACIT, Genesys Capital, HealthCap, Johnson & Johnson Innovation - JJDC, Inc., and TPG Biotech.

    Comment?

  4. New York State Common Retirement Fund Has $32.53 Million Stake in Varian Medical Systems, Inc.Read the original story w/Photo

    Sep 25, 2017 | Daily Political

    New York State Common Retirement Fund decreased its position in Varian Medical Systems, Inc. by 41.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission . The firm owned 315,262 shares of the medical equipment provider's stock after selling 227,056 shares during the period.

    Comment?

  5. Fusion Pharmaceuticals lands $21 mlnRead the original story

    Sep 25, 2017 | PE Hub

    Hamilton, Ontario-based Fusion Pharmaceuticals , a clinical-stage biopharmaceutical company, has raised an additional $21 million in Series A funding, bringing the total tally to $46 million. The investors in this round included Adams Street Partners, Seroba Life Sciences and Varian Medical Systems Inc. Hamilton, Ontario-based Fusion Pharmaceuticals , a clinical-stage biopharmaceutical company, has raised an additional $21 million in Series A funding, bringing the total tally to $46 million.

    Comment?

  6. Fusion Pharma Drums Up Another $21 Million, Bringing Its Total Series A Raise to $46 MillionRead the original story

    Sep 24, 2017 | BioSpace

    Fusion Pharmaceuticals , a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced it has completed a second closing of its Series A financing, securing an additional $21 million USD in capital and bringing the total capital raised to $46 million USD. New investors in the second closing include Adams Street Partners , Seroba Life Sciences , and Varian Medical Systems Inc. , who join the existing group of international investors, FACIT , Genesys Capital , HealthCap , Johnson & Johnson Innovation - JJDC, Inc. , and TPG Biotech .

    Comment?

  7. Fusion Pharma Completes Oversubscribed Series A Financing Totaling...Read the original story

    Sep 24, 2017 | BioSpace

    Fusion Pharmaceuticals , a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced it has completed a second closing of its Series A financing, securing an additional $21 million USD in capital and bringing the total capital raised to $46 million USD. New investors in the second closing include Adams Street Partners , Seroba Life Sciences , and Varian Medical Systems Inc. , who join the existing group of international investors, FACIT , Genesys Capital , HealthCap , Johnson & Johnson Innovation - JJDC, Inc. , and TPG Biotech .

    Comment?

  8. Varian Medical Systems (VAR) Getting Somewhat Favorable Press Coverage, Report FindsRead the original story w/Photo

    Sep 24, 2017 | Daily Political

    News coverage about Varian Medical Systems has trended somewhat positive recently, according to Accern. The research firm rates the sentiment of media coverage by monitoring more than 20 million news and blog sources in real-time.

    Comment?

  9. First Trust Advisors LP Reduces Position in Varian Medical Systems, Inc.Read the original story w/Photo

    Sep 23, 2017 | IntersportsWire

    First Trust Advisors LP decreased its stake in shares of Varian Medical Systems, Inc. by 94.7% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 8,175 shares of the medical equipment provider's stock after selling 145,603 shares during the quarter.

    Comment?

  10. A one of a kind machine is helping to extend the lives of cancer stricken pets.Read the original story w/Photo

    Sep 22, 2017 | San Jose Mercury News

    ... going to do euthanasia,'" Te Winkle said. The therapy comes from a Halcyon machine, engineered by Varian Medical Systems. The first one was installed at SAGE last month, and the first radiation treatment was delivered on Sept. 7 to a dog named ...

    Comment?

  11. Campbell pet hospital offers new hope for cancer-stricken animalsRead the original story

    Sep 22, 2017 | Contra Costa Times

    ... going to do euthanasia,'" Te Winkle said. The therapy comes from a Halcyon machine, engineered by Varian Medical Systems. The first one was installed at SAGE last month, and the first radiation treatment was delivered on Sept. 7 to a dog named ...

    Comment?

  12. Latin America Minimally Invasive Surgery Market: Technological...Read the original story w/Photo

    Sep 22, 2017 | SBWire

    ... Latin America minimally invasive surgery market are Stryker Corporation, Abbott Laboratories, Inc., Varian Medical Systems, Inc., Siemens Healthcare, GE Healthcare, Medtronic, Inc., Teleflex, Covidien plc, DePuy Synthes, Inc., Biomet, Inc., and ...

    Comment?

  13. Van ECK Associates Corp Sells 126,792 Shares of Varian Medical Systems, Inc.Read the original story w/Photo

    Sep 22, 2017 | IntersportsWire

    Van ECK Associates Corp cut its position in shares of Varian Medical Systems, Inc. by 43.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 163,494 shares of the medical equipment provider's stock after selling 126,792 shares during the quarter.

    Comment?

  14. Analysis on Global Image Guided Surgery Sector with Detailed Forecast ...Read the original story w/Photo

    Sep 21, 2017 | SBWire

    ... for each company. As per report the top competitors include General Electric, Zimmer Holdings, Inc., Varian Medical Systems, Inc., Cacon, St. Jude Medical, Inc., Smith & Nephew, Siemens AG, Medtronic, Inc., Koninklijke Philips N.V., KARL STORZ GmbH ...

    Comment?

  15. Varian Medical Systems Announces Penn Medicine Treats World's First Patient On Halcyon SystemRead the original story w/Photo

    Sep 20, 2017 | BioSpace

    /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced a patient at Penn Medicine, with head & neck cancer, became the first person in the world to be treated on Varian's Halcyon system, its new platform for cancer treatment. Halcyon is ...

    Comment?

  16. South Texas Money Management Ltd. Trims Stake in Varian Medical Systems, Inc.Read the original story w/Photo

    Sep 20, 2017 | Daily Political

    South Texas Money Management Ltd. reduced its holdings in Varian Medical Systems, Inc. by 3.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission . The firm owned 269,535 shares of the medical equipment provider's stock after selling 9,016 shares during the period.

    Comment?

  17. Varian Ranks First in Overall Manufacturer, System, and Service...Read the original story

    Sep 20, 2017 | Customer Interaction Solutions

    /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced it has been ranked first in eight categories, including overall manufacturer performance, overall system performance and overall service performance in the ServiceTrak Imaging 2017 ...

    Comment?

  18. Varian Expands Clinicians' Cancer-fighting Toolkit with Eclipse 15.5Read the original story

    Sep 18, 2017 | Information Technology

    /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced the newest release of its treatment planning system, Eclipse 15.5. This new release has received FDA 510(k) clearance, and incorporates several new treatment capabilities that offer ...

    Comment?

  19. Varian Expands Clinicians' Cancer-fighting Toolkit with Eclipse 15.5Read the original story

    Sep 18, 2017 | BroadcastNewsroom

    Highlights- Eclipse? 15.5 treatment planning software receives FDA 510 clearance- Treatment planning for Varian HyperArc? High Definition Radiotherapy now available- Multi-criteria optimizat... /PRNewswire/ -- Varian Medical Systems today announced the newest release of its treatment planning system, Eclipse 15.5. This new release has received FDA 510 clearance, and incorporates several new treatment capabilities that offer clinicians the ability to create more precise treatment plans quickly. Eclipse 15.5 also provides treatment planning support for Varian's HyperArc HDRT, a new type of radiosurgery treatment.

    Comment?

  20. Financial Contrast: AccurayRead the original story w/Photo

    Sep 17, 2017 | Daily Political

    Accuray and Varian Medical Systems are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Accuray has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500.

    Comment?